Monday, April 21, 2014
$1,000-a-day miracle drug shocks U.S. health care system - CBS News
Something definitely seems wrong here...
AT CBSnews.com, Kim Peterson offers these points among others:
"Taxpayers: More than half of those with hepatitis C are veterans, prisoners, uninsured or on Medicaid, the New York Times reports. That requires taxpayers to pick up the bill.
Lawmakers: Perhaps motivated by the high costs to taxpayers, lawmakers are pushing Gilead to explain why it charges so much. It doesn't help that Gilead is offering Sovaldi in Egypt at a 99 percent discount to U.S. prices, or about $900 for a full course of treatment."
